768 related articles for article (PubMed ID: 7536664)
1. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
2. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate.
Borgenström M; Tienhaara A; Spillmann D; Salmivirta M; Jalkanen M
Exp Cell Res; 2001 Apr; 264(2):307-14. PubMed ID: 11262187
[TBL] [Abstract][Full Text] [Related]
3. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
[TBL] [Abstract][Full Text] [Related]
4. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
5. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
Leppä S; Härkönen P; Jalkanen M
Cell Regul; 1991 Jan; 2(1):1-11. PubMed ID: 2007184
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells.
Viklund L; Vorontsova N; Henttinen T; Salmivirta M
Growth Factors; 2006 Jun; 24(2):151-7. PubMed ID: 16801134
[TBL] [Abstract][Full Text] [Related]
7. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
[TBL] [Abstract][Full Text] [Related]
8. A role for heparan sulfate in androgen-induced deoxyribonucleic acid synthesis of mouse mammary carcinoma (Shionogi carcinoma 115)-derived SC-3 cells.
Sumitani S; Kasayama S; Sato B
Endocrinology; 1993 Mar; 132(3):1199-206. PubMed ID: 8440181
[TBL] [Abstract][Full Text] [Related]
9. Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115.
Kasayama S; Sumitani S; Tanaka A; Yamanishi H; Nakamura N; Matsumoto K; Sato B
J Cell Physiol; 1991 Aug; 148(2):260-6. PubMed ID: 1715343
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].
Koga M; Kouhara H; Sato B
Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813
[TBL] [Abstract][Full Text] [Related]
11. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
[TBL] [Abstract][Full Text] [Related]
12. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity.
Filla MS; Dam P; Rapraeger AC
J Cell Physiol; 1998 Mar; 174(3):310-21. PubMed ID: 9462693
[TBL] [Abstract][Full Text] [Related]
13. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
[TBL] [Abstract][Full Text] [Related]
14. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
[TBL] [Abstract][Full Text] [Related]
15. Expression of the androgen-dependent MMTV-specific orf gene in Shionogi 115 mouse mammary tumor cells.
Valve EM; Ruohola JK; Tasanen MJ; Glover JF; Darbre PD; Härkönen PL
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):389-400. PubMed ID: 11738549
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K
Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270
[TBL] [Abstract][Full Text] [Related]
17. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Nishizawa Y; Terada N; Matsumoto K; Sato B
Cancer Res; 1991 Jun; 51(11):3006-10. PubMed ID: 2032238
[TBL] [Abstract][Full Text] [Related]
19. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.
Tanaka A; Miyamoto K; Minamino N; Takeda M; Sato B; Matsuo H; Matsumoto K
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8928-32. PubMed ID: 1409588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
